Business Context and Reporting Period
This Form 8-K is a current report filed by Fluidigm Corporation (noted as Standard BioTools Inc. in metadata) on March 9, 2011. The filing serves to announce the company's financial results for the fiscal quarter and fiscal year ended December 31, 2010.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the press release furnished as Exhibit 99.1, which is not included in the provided text.
Material Changes
The filing does not detail specific material changes versus prior periods. It solely references the issuance of a press release reporting the results for the period ended December 31, 2010.
Guidance, Outlook, and Risks
The text contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. The report explicitly states that the information furnished under Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or incorporated by reference in other filings, except as expressly set forth by specific reference.
Investor Verification Checklist
- Verify the specific revenue and net income figures for the quarter and year ended December 31, 2010, by reviewing Exhibit 99.1 (the press release).
- Confirm the company's current legal name, as the metadata lists "Standard BioTools Inc." while the filing header lists "Fluidigm Corporation."
- Review the full press release for any forward-looking statements or guidance not captured in this summary.
- Note that the financial data in this 8-K is not incorporated by reference into other SEC filings unless specifically cited.